Pharmadrug Inc.
PHRX
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 97.43% | 94.29% | -1,034.00% | -660.66% | -91.84% |
| Total Depreciation and Amortization | 26.57% | 90.16% | 761.97% | 1,500.00% | 376.67% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -89.95% | -47.95% |
| Total Other Non-Cash Items | -98.11% | -97.98% | 332.57% | 6,725.11% | 153.44% |
| Change in Net Operating Assets | -284.07% | -201.74% | -192.31% | -205.56% | -76.58% |
| Cash from Operations | 80.05% | -12.43% | -139.13% | -106.49% | -1.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -125.29% | -104.58% | -100.08% | -97.69% | -84.61% |
| Cash from Investing | -101.49% | -101.17% | 111.24% | 116.34% | 158.25% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | 6,566.67% |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | 19.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -63.98% | -60.65% | -118.74% | 1,011.72% | 261.88% |
| Cash from Financing | -100.64% | 41.02% | 30.56% | 16.44% | -14.39% |
| Foreign Exchange rate Adjustments | -200.00% | -177.27% | -85.71% | 100.72% | 117.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -100.00% | -100.00% |
| Net Change in Cash | -172.99% | -181.16% | -118.97% | 350.24% | 1,063.92% |